Connect with us

Dolmatil (sulpiride)

Sulpiride (or DOLMATIL®) is mainly prescribed to treat schizophrenia and major depressive disorder.

First Approval: 1991 (International: Asia, Europe, Central America, South America, Africa)

Dosage Forms: 200 mg, 400 mg, 600 mg, 800 mg, 1,200 mg

Biological Half-life: 6-8 hours

Side Effects: Dizziness, blurred vision, rashes, constipation, libido changes, weight gain

Routes of Administration: Oral, IM

Pregnancy Category: N/A

  www.sulpiride.com

Like Us

Advertisement
Advertisement